Adaptive and innate regulation of immune privilege
免疫豁免的适应性和先天调节
基本信息
- 批准号:8114426
- 负责人:
- 金额:$ 63.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAntibodiesAntigen-Presenting CellsAntigensBlood CellsCD8B1 geneCellsChimera organismComplementCytotoxic T-LymphocytesDelayed HypersensitivityDevelopmentDiseaseEffector CellEyeEye diseasesFundingGelatinase BGenerationsGenesGoalsHumanIL2RA geneImmuneImmune responseImmunityImmunologyIn VitroInflammatoryKnowledgeLaboratoriesMMP9 geneMalpighian corpusclesManuscriptsMediatingMolecularNaturePhysiologic pulsePlayPopulationPreparationPublishingRegulationRegulatory T-LymphocyteRetinoic Acid ReceptorRoleSCID MiceSpleenT cell regulationTestingTissuesToxic effectUveitisacronymsanterior chamberbasedeviantin vivomouse modelpathogenpreventresponsetreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Systemic immunity to anterior chamber antigens is deviant; certain immune effectors (delayed hypersensitivity, Th2 responses, complement fixing antibodies) are deleted/suppressed, whereas others (cytotoxic T cells, non-complement fixing antibodies) are promoted. Anterior Chamber Associated Immune Deviation (ACAID) is an important expression of ocular immune privilege. During previous funding periods, our ACAID studies (i) showed that induction of ACAID CD8+ and ACAID CD4+ CD25- Tregs occurs in the marginal zone of the spleen rather than the white pulp while the generation of ACAID CD4+ CD25+ Treg does not; (ii) defined the genes associated with ACAID CD8+ Treg cells and showed that CD103, FoxP3 and MMP9 are necessary for ACAID efferent suppression. Based on these results, we propose an experimental plan for the next five years with the following three aims: (i) Compare and contrast ACAID CD4+ regulatory T cell subpopulations in regards to their mechanisms of suppression. (ii) Determine the mechanisms used by ACAID CD8+ Treg to suppress of CD4+ T effector cells, focusing on particular mechanisms used by CD8+ Treg derived - MMP9 and - retinoic acid receptor; (iii) test the significance of our findings for human immunology by studying ACAID Treg cells in a human chimera mouse model for ACAID. Our long-term goal is to push our understanding of ACAID and ocular immune privilege to the molecular level, and then to devise treatment strategies of very limited (or no) toxicity that prevent or suppress ocular inflammatory diseases (uveitis), or (ii) alleviate multifactorial eye diseases.
PUBLIC HEALTH RELEVANCE: Understanding the basis for immunity within the eye, as well as appreciating the nature of immune responses to eye-derived antigens and pathogens are of considerable importance to other tissues as well as the eye. The studies will add new information to the field of T cell regulation in the eye and the periphery.
描述(由申请人提供):对前房抗原的全身免疫异常;某些免疫效应器(延迟超敏反应、Th2反应、补体固定抗体)被删除/抑制,而其他免疫效应器(细胞毒性T细胞、非补体固定抗体)被促进。前房相关免疫偏差(ACAID)是眼部免疫特权的重要表现。在之前的资助期内,我们的ACAID研究(i)表明,ACAID CD8+和ACAID CD4+ CD25- Treg的诱导发生在脾脏边缘区,而不是白髓,而ACAID CD4+ CD25+ Treg的产生则不会;(ii)明确了与ACAID相关的CD8+ Treg细胞基因,发现CD103、FoxP3和MMP9是ACAID输出抑制所必需的。基于这些结果,我们提出了未来五年的实验计划,主要有以下三个目标:(i)比较和对比ACAID CD4+调节性T细胞亚群的抑制机制。(ii)确定ACAID CD8+ Treg抑制CD4+ T效应细胞的机制,重点关注CD8+ Treg衍生的- MMP9和-视黄酸受体的特定机制;(iii)通过在ACAID人嵌合体小鼠模型中研究ACAID Treg细胞来检验我们的发现对人类免疫学的意义。我们的长期目标是将我们对ACAID和眼部免疫特权的理解推进到分子水平,然后设计出非常有限(或没有)毒性的治疗策略,以预防或抑制眼部炎症性疾病(葡萄膜炎),或者(ii)减轻多因素眼病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joan Stein-Streilein其他文献
Joan Stein-Streilein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joan Stein-Streilein', 18)}}的其他基金
Mechanisms of Ocular Immune Privilege in the Posterior Eye
后眼的眼部免疫特权机制
- 批准号:
8047973 - 财政年份:2010
- 资助金额:
$ 63.39万 - 项目类别:
Mechanisms of Ocular Immune Privilege in the Posterior Eye
后眼的眼部免疫特权机制
- 批准号:
7872399 - 财政年份:2010
- 资助金额:
$ 63.39万 - 项目类别:
Adaptive and innate regulation of immuneprivilege
免疫特权的适应性和先天调节
- 批准号:
7388130 - 财政年份:2006
- 资助金额:
$ 63.39万 - 项目类别:
Adaptive and innate regulation of immuneprivilege
免疫特权的适应性和先天调节
- 批准号:
7195014 - 财政年份:2006
- 资助金额:
$ 63.39万 - 项目类别:
Adaptive and innate regulation of immune privilege
免疫豁免的适应性和先天调节
- 批准号:
7618420 - 财政年份:2006
- 资助金额:
$ 63.39万 - 项目类别:
Adaptive and innate regulation of immune privilege.
免疫特权的适应性和先天调节。
- 批准号:
7093212 - 财政年份:2006
- 资助金额:
$ 63.39万 - 项目类别:
Adaptive and innate regulation of immune privilege.
免疫特权的适应性和先天调节。
- 批准号:
7568382 - 财政年份:2006
- 资助金额:
$ 63.39万 - 项目类别:
CHEMOKINE REGULATION OF NKT CELLS, AND ACAID
NKT 细胞的趋化因子调节和 ACAID
- 批准号:
6637202 - 财政年份:2000
- 资助金额:
$ 63.39万 - 项目类别:
CHEMOKINE REGULATION OF NKT CELLS, AND ACAID
NKT 细胞的趋化因子调节和 ACAID
- 批准号:
6525048 - 财政年份:2000
- 资助金额:
$ 63.39万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 63.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists